Physician profile
Andy Li
NPI 1568048742
$351.73
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.49 · 2023: $257 · 2024: $44.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $86.99 | 2022-2023 | Sublocade |
| Novo Nordisk INC | $74.42 | 2023 | Wegovy |
| Glaxosmithkline, LLC. | $42.08 | 2022-2024 | Trelegy Ellipta |
| Braeburn INC. | $32.96 | 2023 | Brixadi |
| Orexo US, INC. | $29.41 | 2022-2023 | |
| Abbvie INC. | $28.55 | 2023-2024 | |
| Exact Sciences Corporation | $24.69 | 2023 | Cologuard Collection Kit |
| Antares Pharma, INC. | $16.82 | 2023 | Xyosted, Tlando, Nocdurna |
| Lilly USA, LLC | $15.81 | 2024 | Zepbound, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.